Latest News about Initiation
Recent news which mentions Initiation
Concentra's High-Quality Business Model Attracts Analyst Attention, Initiates With Buy Rating
August 19, 2024
From Benzinga
From Benzinga
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
August 15, 2024
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch
August 13, 2024
From Benzinga
Packaged Food Sector To See Mixed Performance Amid Economic Headwinds: Goldman Sachs
August 12, 2024
From Benzinga
New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View
August 12, 2024
From Benzinga
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
July 31, 2024
From Benzinga
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
July 30, 2024
Tickers
MOVE
From Benzinga
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
From Benzinga
From Benzinga
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
July 22, 2024
From Benzinga
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
July 22, 2024
From Benzinga
What's Going On With Shopify Shares Today?
July 17, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
